Literature DB >> 21936750

Transmission of resistant HIV type 1 variants and epidemiological chains in Italian newly diagnosed individuals.

Alessia Lai1, Michela Violin, Erika Ebranati, Marco Franzetti, Valeria Micheli, Maria Rita Gismondo, Amedeo Capetti, Paola Meraviglia, Francesco Roberto Simonetti, Giorgio Bozzi, Masimo Ciccozzi, Massimo Galli, Gianguglielmo Zehender, Claudia Balotta.   

Abstract

Transmission of HIV-1 and drug resistance continue to occur at a considerable level in Italy, influenced mainly by changes in modality of infection. However, the long period of infectivity makes difficult the interpretation of epidemiological networks, based on epidemiological data only. We studied 510 naive HIV-1-infected individuals, of whom 400 (78.4%) were newly diagnosed patients with an unknown duration of infection (NDs), with the aim of identifying sexual epidemiological networks and transmitted drug resistance (TDR) over a 7-year period. Clusters were identified by Bayesian methods for 412 patients with B subtype; 145 individuals (35.2%) clustered in 34 distinct clades. Within epidemiological networks males were 93.1% (n=135); the same proportion of patients has been infected by the sexual route; 62.1% (n=90) were men having sex with men (MSM) of whom 67.8% (n=61) were NDs. Among heterosexuals (n=44), males were predominant (79.5%, n=35) and 77.3% (n=34) were NDs. TDR in clusters was 11.7 % (n=17), of whom 76.5% (n=13) was found in MSM. TDR was predominantly associated with NRTI resistance in individuals with chronic infection (n=11). A high prevalence of epidemiological networks has been found in the metropolitan area of Milan, indicating a high frequency of transmission events. The cluster analysis of networks suggested that the source of new infections was mainly represented by males and MSM who have long lasting HIV-1 infection. Notably, the prevalence of resistance-conferring mutations was higher in chronically infected patients, carrying mainly resistance to thymidine analogs, the backbone of first antiretroviral (ARV) generation. Intervention strategies of public health are needed to limit HIV-1 transmission and the associated TDR.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21936750      PMCID: PMC3399563          DOI: 10.1089/aid.2011.0245

Source DB:  PubMed          Journal:  AIDS Res Hum Retroviruses        ISSN: 0889-2229            Impact factor:   2.205


  24 in total

1.  MRBAYES: Bayesian inference of phylogenetic trees.

Authors:  J P Huelsenbeck; F Ronquist
Journal:  Bioinformatics       Date:  2001-08       Impact factor: 6.937

2.  Bayesian selection of continuous-time Markov chain evolutionary models.

Authors:  M A Suchard; R E Weiss; J S Sinsheimer
Journal:  Mol Biol Evol       Date:  2001-06       Impact factor: 16.240

3.  Surveillance of HIV antiretroviral drug resistance in treated individuals in England: 1998-2000.

Authors:  Paul Scott; Eve Arnold; Barry Evans; Anton Pozniak; Graeme Moyle; Mohsen Shahmenesh; David White; Jane Shirley; Patricia Cane; Deenan Pillay
Journal:  J Antimicrob Chemother       Date:  2004-01-28       Impact factor: 5.790

Review 4.  Current patterns in the epidemiology of primary HIV drug resistance in North America and Europe.

Authors:  Deenan Pillay
Journal:  Antivir Ther       Date:  2004-10

5.  Genetic analysis reveals the complex structure of HIV-1 transmission within defined risk groups.

Authors:  Stéphane Hué; Deenan Pillay; Jonathan P Clewley; Oliver G Pybus
Journal:  Proc Natl Acad Sci U S A       Date:  2005-03-14       Impact factor: 11.205

6.  Comparative population dynamics of HIV-1 subtypes B and C: subtype-specific differences in patterns of epidemic growth.

Authors:  Polly R Walker; Oliver G Pybus; Andrew Rambaut; Edward C Holmes
Journal:  Infect Genet Evol       Date:  2004-12-07       Impact factor: 3.342

7.  Epidemiological network analysis in HIV-1 B infected patients diagnosed in Italy between 2000 and 2008.

Authors:  Annapaola Callegaro; Valentina Svicher; Claudia Alteri; Alessandra Lo Presti; Daniela Valenti; Antonio Goglio; Marco Salemi; Eleonora Cella; Carlo Federico Perno; Massimo Ciccozzi; Franco Maggiolo
Journal:  Infect Genet Evol       Date:  2011-02-01       Impact factor: 3.342

8.  Antiretroviral-drug resistance among patients recently infected with HIV.

Authors:  Susan J Little; Sarah Holte; Jean-Pierre Routy; Eric S Daar; Marty Markowitz; Ann C Collier; Richard A Koup; John W Mellors; Elizabeth Connick; Brian Conway; Michael Kilby; Lei Wang; Jeannette M Whitcomb; Nicholas S Hellmann; Douglas D Richman
Journal:  N Engl J Med       Date:  2002-08-08       Impact factor: 91.245

9.  Time trends in primary HIV-1 drug resistance among recently infected persons.

Authors:  Robert M Grant; Frederick M Hecht; Maria Warmerdam; Lea Liu; Teri Liegler; Christos J Petropoulos; Nicholas S Hellmann; Margaret Chesney; Michael P Busch; James O Kahn
Journal:  JAMA       Date:  2002-07-10       Impact factor: 56.272

10.  Prevalence of transmitted HIV-1 drug resistance and the role of resistance algorithms: data from seroconverters in the CASCADE collaboration from 1987 to 2003.

Authors:  Bernard Masquelier; Krishnan Bhaskaran; Deenan Pillay; Robert Gifford; Eric Balestre; Louise Bruun Jørgensen; Court Pedersen; Lia van der Hoek; Maria Prins; Claudia Balotta; Benedetta Longo; Claudia Kücherer; Gabriele Poggensee; Marta Ortiz; Carmen de Mendoza; John Gill; Hervé Fleury; Kholoud Porter
Journal:  J Acquir Immune Defic Syndr       Date:  2005-12-15       Impact factor: 3.731

View more
  6 in total

Review 1.  Burden of nonnucleoside reverse transcriptase inhibitor resistance in HIV-1-infected patients: a systematic review and meta-analysis.

Authors:  Sonya J Snedecor; Lavanya Sudharshan; Katherine Nedrow; Abhijeet Bhanegaonkar; Kit N Simpson; Seema Haider; Richard Chambers; Charles Craig; Jennifer Stephens
Journal:  AIDS Res Hum Retroviruses       Date:  2014-07-08       Impact factor: 2.205

2.  Trends in prevalence of HIV-1 drug resistance in Thailand 2009-2010.

Authors:  Sayompoo Sanguansittianant; Nattakarn Nooroon; Poonlaph Phaengchomduan; Palanee Ammaranond
Journal:  J Clin Lab Anal       Date:  2013-09       Impact factor: 2.352

3.  HIV-1 subtype F1 epidemiological networks among Italian heterosexual males are associated with introduction events from South America.

Authors:  Alessia Lai; Francesco R Simonetti; Gianguglielmo Zehender; Andrea De Luca; Valeria Micheli; Paola Meraviglia; Paola Corsi; Patrizia Bagnarelli; Paolo Almi; Alessia Zoncada; Stefania Paolucci; Angela Gonnelli; Grazia Colao; Danilo Tacconi; Marco Franzetti; Massimo Ciccozzi; Maurizio Zazzi; Claudia Balotta
Journal:  PLoS One       Date:  2012-08-02       Impact factor: 3.240

4.  HIV-1 subtype D infections among Caucasians from Northwestern Poland--phylogenetic and clinical analysis.

Authors:  Miłosz Parczewski; Magdalena Leszczyszyn-Pynka; Dorota Bander; Anna Urbanska; Anna Boroń-Kaczmarska
Journal:  PLoS One       Date:  2012-02-16       Impact factor: 3.240

5.  HIV-1 transmission patterns in antiretroviral therapy-naïve, HIV-infected North Americans based on phylogenetic analysis by population level and ultra-deep DNA sequencing.

Authors:  Lisa L Ross; Joseph Horton; Samiul Hasan; James R Brown; Daniel Murphy; Edwin DeJesus; Martin Potter; Anthony LaMarca; Ivan Melendez-Rivera; Douglas Ward; Jonathon Uy; Mark S Shaefer
Journal:  PLoS One       Date:  2014-02-26       Impact factor: 3.240

6.  Early-Transmitted Variants and Their Evolution in a HIV-1 Positive Couple: NGS and Phylogenetic Analyses.

Authors:  Alessia Lai; Vania Giacomet; Annalisa Bergna; Gian Vincenzo Zuccotti; Gianguglielmo Zehender; Mario Clerici; Daria Trabattoni; Claudio Fenizia
Journal:  Viruses       Date:  2021-03-19       Impact factor: 5.048

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.